Results 101 to 110 of about 15,167 (190)

EFFICACY OF HYDRALAZINE IN COMPARISON WITH LABETALOL FOR CONTROL OF SEVERE HYPERTENSION IN PATIENTS WITH ECLAMPSIA

Pakistan Armed Forces Medical Journal, 2020
Objective: To compare the efficacy of intravenous hydralazine with intravenous labetalol for control of severe hypertension in eclamptic patients. Study Design: Cross-sectional study. Place and Duration of Study: Obstetrics and Gynecology unit “B”,
Mehwish Syed, Rizwan Faisal, Laiyla Shinwari, Afrah Aman, Rabia Nawaz, Sumayya   +5 more
doaj  

Vasodilative effect of hydralazine in awake dogs: the roles of prostaglandins and the sympathetic nervous system.

, 1984
The relative roles of prostaglandins and the sympathetic nervous system in mediating the hypotensive effects of hydralazine were studied in awake dogs with and without pretreatment with indomethacin, propranolol, and phentolamine.
K Maekawa, A Tsui, B T Chen, S Kawashima, C S Liang   +4 more
core   +1 more source

Drug‐Induced Renal Vasculitis: Etiology, Pathogenesis, Clinical Manifestations, and Therapeutic Approaches—A Narrative Review

Health Science Reports
Background and Aims Drug‐induced renal vasculitis arises from various medications that cause immunological dysregulation or direct vascular damage, leading to inflammation and thrombosis.
Hashim Mohamed Siraj, Masab Ali, Sampda Sanjaykumar Sharma, Afreen Begum, Muhammad Husnain Ahmad, Muhammad Hassan, Roba Kamaleldin Moustafa Kamel Aref Elsayed, Muhammad Hamza Tahir   +7 more
doaj   +1 more source

Effects of verapamil, papaverine, sodium nitrite, and hydralazine on ethyl alcohol-induced contraction of the isolated human umbilical artery

The Turkish Journal of Pediatrics, 1989
In this in vitro study, the vasodilator effects of certain drugs such as verapamil, papaverine, sodium nitrite and hydralazine on ethyl alcohol-induced contractions were investigated in the isolated human umbilical artery.
E Singirik, U Calişkan, A G Cenik, N Doğan   +3 more
doaj  

Hydralazine-associated antineutrophil cytoplasmic antibody vasculitis with pulmonary-renal syndrome

, 2018
Hydralazine, a vasodilator, is commonly used as an adjunctive treatment for moderate to severe hypertension, heart failure and hypertensive emergencies in pregnancy. Hydralazine-induced lupus was first described in 1953. Clinical presentation ranges from
Ansari, Asif, Pathireddy, Samata, Juran, Peter J., Aeddula, Narothama Reddy   +3 more
core   +1 more source

Development and Optimization of Gastro-Retentive Formulation of Hydralazine HCl

, 2016
Hydralazine hydrochloride has a half-life of 2 to 4 hours with an oral bioavailability of 26-50%. Since hydralazine has a demethylating effect on various suppressor genes, it can be used in various types of cancer to support chemotherapy.
Rakesh Patel, Himanshu Acharya
core   +1 more source

Furosemide versus Hydralazine for Managing Post Partum Hypertension in Severe Preeclampsia: A Comparative Study

Majallah-i Dānishgāh-i ’Ulūm-i Pizishkī-i Shahīd Ṣadūqī Yazd, 2012
Introduction: Gestational hypertension and preeclampsia are important maternal and fetal– infant complications and they can be regarded as the second cause of maternal death as well.
M Behrashi, AR Nobakht, A Zabihi Mahmoodabadi, Gh Musavi   +3 more
doaj  

Effect of hydralazine on aortic rupture induced by B-aminopropionitrile in turkeys.

, 1982
The effects of hydralazine on aortic rupture, hemodynamics and aortic ultrastructure were studied in turkeys fed B-aminopropionitrile (BAPN). A mortality rate of 24% due to hemopericardium and internal hemorrhage in turkeys fed only BAPN increased to 91%
C F Simpson, W J Taylor
core   +1 more source

Hydralazine-Induced ANCA Associated Vasculitis (AAV) Presenting with Pulmonary-Renal Syndrome (PRS): A Case Report with Literature Review

, 2020
Hydralazine, an arterial vasodilator, is a widely used medication for the management of hypertension and heart failure, especially for patients who cannot tolerate the use of ACEIs or ARBs. It is generally well tolerated and has safe profile in pregnancy.
Battisha, Ayman, MD
core   +1 more source

Effects of six-month afterload reduction therapy with hydralazine in chronic aortic regurgitation.

, 1986
Seventeen patients with chronic asymptomatic aortic regurgitation (AR) were studied to determine whether 6 months of hydralazine therapy can reduce the severity of AR or reverse left ventricular (LV) enlargement and hypertrophy.
Muhammed, A, Chandler, T, Kleaveland, J Patrick, MD, Priest, C, Reichek, N, McCarthy, D M, Hirshfeld, J, Makler, P T   +7 more
core   +1 more source